Gunnar Sæter

4.6k total citations
77 papers, 3.4k citations indexed

About

Gunnar Sæter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Gunnar Sæter has authored 77 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 15 papers in Surgery. Recurrent topics in Gunnar Sæter's work include Sarcoma Diagnosis and Treatment (53 papers), Vascular Tumors and Angiosarcomas (19 papers) and Bone Tumor Diagnosis and Treatments (14 papers). Gunnar Sæter is often cited by papers focused on Sarcoma Diagnosis and Treatment (53 papers), Vascular Tumors and Angiosarcomas (19 papers) and Bone Tumor Diagnosis and Treatments (14 papers). Gunnar Sæter collaborates with scholars based in Norway, Sweden and Finland. Gunnar Sæter's co-authors include Thor Alvegård, Anna E. Stenwig, Henrik C. F. Bauer, Sigbjørn Smeland, Inkeri Elomaa, Thomas Wiebe, Carl Blomqvist, Pelle Gustafson, Clement Trovik and Per O. Seglen and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Gunnar Sæter

75 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gunnar Sæter Norway 33 2.4k 1.3k 1.0k 646 547 77 3.4k
G. Bacci Italy 35 3.2k 1.3× 1.2k 0.9× 1.5k 1.5× 1.0k 1.6× 557 1.0× 145 4.0k
Thor Alvegård Sweden 33 2.7k 1.1× 1.6k 1.2× 898 0.9× 837 1.3× 355 0.6× 81 3.3k
Beate Kempf‐Bielack Germany 14 2.3k 0.9× 1.0k 0.8× 995 1.0× 573 0.9× 909 1.7× 17 3.4k
Alessandro Comandone Italy 25 2.3k 1.0× 1.4k 1.1× 913 0.9× 621 1.0× 420 0.8× 103 3.0k
Arthur P. Staddon United States 29 2.4k 1.0× 1.4k 1.1× 1.1k 1.1× 318 0.5× 652 1.2× 67 3.5k
James E. Butrynski United States 26 2.0k 0.8× 1.2k 0.9× 738 0.7× 506 0.8× 654 1.2× 52 3.3k
Silke Flege Germany 14 2.0k 0.8× 761 0.6× 1.0k 1.0× 633 1.0× 757 1.4× 22 2.9k
Philippe Terrier France 31 2.2k 0.9× 963 0.7× 1.2k 1.2× 404 0.6× 519 0.9× 60 3.3k
Adrián Mariño‐Enríquez United States 35 2.2k 0.9× 861 0.7× 1.1k 1.1× 447 0.7× 734 1.3× 94 3.6k
Federica Grosso Italy 33 3.0k 1.3× 1.8k 1.4× 633 0.6× 535 0.8× 642 1.2× 158 4.4k

Countries citing papers authored by Gunnar Sæter

Since Specialization
Citations

This map shows the geographic impact of Gunnar Sæter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Sæter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Sæter more than expected).

Fields of papers citing papers by Gunnar Sæter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunnar Sæter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Sæter. The network helps show where Gunnar Sæter may publish in the future.

Co-authorship network of co-authors of Gunnar Sæter

This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Sæter. A scholar is included among the top collaborators of Gunnar Sæter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Sæter. Gunnar Sæter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hall, Kirsten Sundby, Anna E. Stenwig, Bodil Bjerkehagen, et al.. (2006). Management of high-grade bone sarcomas over two decades: The Norwegian Radium Hospital experience. Acta Oncologica. 45(1). 38–46. 28 indexed citations
2.
Müller, Christoph R., Sigbjørn Smeland, Henrik C. F. Bauer, Gunnar Sæter, & Hans Strander. (2005). Interferon-α as the only adjuvant treatment in high-grade osteosarcoma: Long term results of the Karolinska Hospital series. Acta Oncologica. 44(5). 475–480. 64 indexed citations
4.
Sæter, Gunnar. (2003). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of osteosarcoma. Annals of Oncology. 14(8). 1165–1166. 15 indexed citations
5.
Sæter, Gunnar. (2003). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Ewing’s sarcoma of bone. Annals of Oncology. 14(8). 1167–1168. 5 indexed citations
6.
Tropé, Claes G., J. Kærn, Gunnar Sæter, & Martin Gore. (2003). [Paclitaxel should be included in standard therapy of ovarian carcinoma].. PubMed. 123(21). 3083–4.
8.
Bauer, Henrik C. F., Clement Trovik, Thor Alvegård, et al.. (2001). Monitoring referral and treatment in soft tissue sarcoma: Study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthopaedica Scandinavica. 72(2). 150–159. 97 indexed citations
9.
Elomaa, Inkeri, Carl Blomqvist, Gunnar Sæter, et al.. (2000). Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. European Journal of Cancer. 36(7). 875–880. 81 indexed citations
10.
Teixeira, Manuel R., et al.. (1999). Combined RxFISH/G-banding allows refined karyotyping of solid tumors. Human Genetics. 104(5). 370–375. 22 indexed citations
11.
Alvegård, Thor & Gunnar Sæter. (1997). The role of pulmonary metastasectomy for soft tissue sarcoma. Acta Orthopaedica Scandinavica. 68(sup273). 145–147. 4 indexed citations
12.
Skullerud, Kari, Anna E. Stenwig, P Brandtzæg, et al.. (1996). Intracranial primary leiomyosarcoma arising in a teratoma of the pineal area.. PubMed. 14(4). 245–8. 22 indexed citations
13.
Solheim, O, Gunnar Sæter, Inkeri Elomaa, & Thor Alvegård. (1992). The treatment of osteosarcoma: Present trends. Annals of Oncology. 3. S7–S11. 17 indexed citations
14.
Lien, H. H., V. Blomlie, Gunnar Sæter, O Solheim, & Sophie D. Fosså. (1991). Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate.. Radiology. 179(2). 547–550. 36 indexed citations
15.
Seglen, Per O., Gunnar Sæter, & Per E. Schwarze. (1990). Liver Tumor Promoters Stimulate Growth of Transplanted Hepatocellular Carcinomas. Hepatology. 12(2). 295–300. 9 indexed citations
16.
Sæter, Gunnar, et al.. (1989). Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells. British Journal of Cancer. 59(2). 198–205. 22 indexed citations
17.
Sæter, Gunnar, Per E. Schwarze, & Per O. Seglen. (1988). Shift From Polyploidizing to Nonpolyploidizing Growth in Carcinogen-Treated Rat Liver1. JNCI Journal of the National Cancer Institute. 80(12). 950–958. 34 indexed citations
18.
Sæter, Gunnar, Per E. Schwarze, Jahn M. Nesland, et al.. (1988). The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas. Carcinogenesis. 9(6). 939–945. 66 indexed citations
19.
Sæter, Gunnar, et al.. (1988). Changes in Ploidy Distributions in Human Liver Carcinogenesis. JNCI Journal of the National Cancer Institute. 80(18). 1480–1484. 47 indexed citations
20.
Holte, Harald, Gunnar Sæter, Inger Marie S. Dahl, & Arne Foss Abrahamsen. (1987). Progressive loss of vision in patients with high-grade non-Hodgkin's lymphoma. Cancer. 60(10). 2521–2523. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026